| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.62e-05 | 130 | 63 | 5 | GO:0005200 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor internalization | 6.80e-06 | 39 | 65 | 4 | GO:0099149 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.29e-05 | 164 | 65 | 6 | GO:0099072 | |
| GeneOntologyBiologicalProcess | postsynaptic endocytosis | 2.01e-05 | 51 | 65 | 4 | GO:0140239 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor internalization | 2.01e-05 | 51 | 65 | 4 | GO:0098884 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 2.68e-05 | 278 | 65 | 7 | GO:0031503 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 3.35e-05 | 58 | 65 | 4 | GO:0099590 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of epithelial cell apical/basal polarity | 3.35e-05 | 58 | 65 | 4 | GO:0045197 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PARD6B DIP2A NEDD4L ANK3 VPS13A OSTN RTN4RL1 CORO1B WLS NYAP1 ACTR2 | 4.56e-05 | 819 | 65 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | establishment or maintenance of bipolar cell polarity | 4.65e-05 | 63 | 65 | 4 | GO:0061245 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of apical/basal cell polarity | 4.65e-05 | 63 | 65 | 4 | GO:0035088 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PARD6B DIP2A NEDD4L ANK3 VPS13A OSTN RTN4RL1 CORO1B WLS NYAP1 ACTR2 | 4.92e-05 | 826 | 65 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | 1.33e-04 | 156 | 65 | 5 | GO:0048259 | |
| GeneOntologyBiologicalProcess | protein localization to adherens junction | 1.45e-04 | 6 | 65 | 2 | GO:0071896 | |
| GeneOntologyBiologicalProcess | neuron projection development | PARD6B DIP2A DLG5 ARID1B NEDD4L ANK3 VPS13A OSTN RTN4RL1 SCRIB WLS NYAP1 ACTR2 | 1.57e-04 | 1285 | 65 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 1.58e-04 | 257 | 65 | 6 | GO:0007163 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 1.83e-04 | 167 | 65 | 5 | GO:0007043 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PARD6B DIP2A NEDD4L ANK3 VPS13A OSTN RTN4RL1 WLS NYAP1 ACTR2 | 1.93e-04 | 802 | 65 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell junction organization | GPHN PARD6B DIP2A DLG5 NEDD4L ANK2 ANK3 IQSEC2 SPTBN2 WNT11 ACTR2 | 2.12e-04 | 974 | 65 | 11 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of endocytosis | 2.18e-04 | 389 | 65 | 7 | GO:0030100 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 2.31e-04 | 95 | 65 | 4 | GO:0002090 | |
| GeneOntologyBiologicalProcess | endocytosis | 2.46e-04 | 827 | 65 | 10 | GO:0006897 | |
| GeneOntologyBiologicalProcess | receptor internalization | 2.72e-04 | 182 | 65 | 5 | GO:0031623 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 2.92e-04 | 101 | 65 | 4 | GO:0097120 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PARD6B DIP2A NEDD4L ANK3 VPS13A OSTN RTN4RL1 CORO1B SCRIB WLS NYAP1 ACTR2 | 3.11e-04 | 1194 | 65 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of keratinocyte differentiation | 4.33e-04 | 10 | 65 | 2 | GO:0045617 | |
| GeneOntologyBiologicalProcess | biomineral tissue development | 4.50e-04 | 203 | 65 | 5 | GO:0031214 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 5.18e-04 | 321 | 65 | 6 | GO:0099003 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 5.44e-04 | 119 | 65 | 4 | GO:0006892 | |
| GeneOntologyBiologicalProcess | neuron development | PARD6B DIP2A DLG5 ARID1B NEDD4L ANK3 VPS13A OSTN RTN4RL1 SCRIB WLS NYAP1 ACTR2 | 5.55e-04 | 1463 | 65 | 13 | GO:0048666 |
| GeneOntologyBiologicalProcess | membrane depolarization | 5.79e-04 | 121 | 65 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | dendrite development | 6.48e-04 | 335 | 65 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 6.68e-04 | 337 | 65 | 6 | GO:0006898 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 7.35e-04 | 56 | 65 | 3 | GO:2001259 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.34e-06 | 477 | 66 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.49e-06 | 9 | 66 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 5.29e-06 | 523 | 66 | 10 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.16e-05 | 451 | 66 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | postsynapse | GPHN USP6 DIP2A DLG5 ANK2 ANK3 SYT11 SPTBN1 IQSEC2 SPTBN2 ARFGEF2 SCRIB ACTR2 | 1.48e-05 | 1018 | 66 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.76e-05 | 503 | 66 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.27e-04 | 31 | 66 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | glutamatergic synapse | USP6 DIP2A DLG5 NEDD4L SPTBN1 IQSEC2 SPTBN2 ARFGEF2 CORO1B SCRIB | 2.28e-04 | 817 | 66 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | spectrin | 3.48e-04 | 9 | 66 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | paranodal junction | 5.30e-04 | 11 | 66 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 7.39e-04 | 56 | 66 | 3 | GO:0099091 | |
| HumanPheno | Short nose | 8.72e-06 | 325 | 24 | 9 | HP:0003196 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 1.97e-05 | 12 | 24 | 3 | HP:0010746 | |
| HumanPheno | Aplasia/Hypoplasia involving the nose | 4.77e-05 | 401 | 24 | 9 | HP:0009924 | |
| HumanPheno | Abnormal morphology of the nasal alae | DPYD VAC14 ARID1B NEDD4L TMEM94 SPTBN1 IQSEC2 KMT2A EXTL3 WLS EDA | 5.92e-05 | 639 | 24 | 11 | HP:0000429 |
| HumanPheno | Anteverted nares | DPYD VAC14 ARID1B NEDD4L TMEM94 SPTBN1 IQSEC2 KMT2A EXTL3 WLS | 1.10e-04 | 559 | 24 | 10 | HP:0000463 |
| HumanPheno | Upturned nose | DPYD VAC14 ARID1B NEDD4L TMEM94 SPTBN1 IQSEC2 KMT2A EXTL3 WLS | 1.10e-04 | 559 | 24 | 10 | HP:0000427 |
| HumanPheno | Sacral dimple | 1.31e-04 | 110 | 24 | 5 | HP:0000960 | |
| HumanPheno | Abnormal nostril morphology | DPYD VAC14 ARID1B NEDD4L TMEM94 SPTBN1 IQSEC2 KMT2A EXTL3 WLS | 1.39e-04 | 575 | 24 | 10 | HP:0005288 |
| HumanPheno | Sacrococcygeal pilonidal abnormality | 1.56e-04 | 114 | 24 | 5 | HP:0010767 | |
| HumanPheno | Skin dimple | 1.98e-04 | 120 | 24 | 5 | HP:0010781 | |
| HumanPheno | Abnormal finger phalanx morphology | MSX2 FANCB VAC14 ARID1B NEDD4L SPTBN1 IQSEC2 KMT2A EXTL3 WLS EDA | 2.25e-04 | 738 | 24 | 11 | HP:0005918 |
| HumanPheno | Short chin | 2.67e-04 | 69 | 24 | 4 | HP:0000331 | |
| HumanPheno | Impaired social interactions | 2.78e-04 | 129 | 24 | 5 | HP:0000735 | |
| HumanPheno | Abnormal social development | GPHN DPYD WDR45 ARID1B ANK3 SPTBN1 IQSEC2 VPS13A ARFGEF2 KMT2A EXTL3 WLS | 3.15e-04 | 908 | 24 | 12 | HP:0025732 |
| HumanPheno | No social interaction | 3.15e-04 | 6 | 24 | 2 | HP:0008763 | |
| HumanPheno | Short phalanx of finger | 3.75e-04 | 306 | 24 | 7 | HP:0009803 | |
| Domain | Spectrin_bsu | 7.80e-05 | 4 | 68 | 2 | IPR016343 | |
| Domain | ZU5 | 4.63e-04 | 9 | 68 | 2 | SM00218 | |
| Domain | PH_dom-spectrin-type | 4.63e-04 | 9 | 68 | 2 | IPR001605 | |
| Domain | ZU5 | 5.77e-04 | 10 | 68 | 2 | PS51145 | |
| Domain | ZU5 | 8.42e-04 | 12 | 68 | 2 | PF00791 | |
| Domain | ZU5_dom | 8.42e-04 | 12 | 68 | 2 | IPR000906 | |
| Domain | - | 1.33e-03 | 15 | 68 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 1.33e-03 | 15 | 68 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.33e-03 | 15 | 68 | 2 | IPR023394 | |
| Domain | Sec7 | 1.52e-03 | 16 | 68 | 2 | SM00222 | |
| Domain | SEC7 | 1.52e-03 | 16 | 68 | 2 | PS50190 | |
| Domain | Sec7_dom | 1.52e-03 | 16 | 68 | 2 | IPR000904 | |
| Domain | Actinin_actin-bd_CS | 3.15e-03 | 23 | 68 | 2 | IPR001589 | |
| Domain | Spectrin | 3.15e-03 | 23 | 68 | 2 | PF00435 | |
| Domain | ACTININ_2 | 3.15e-03 | 23 | 68 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.15e-03 | 23 | 68 | 2 | PS00019 | |
| Domain | LRR_8 | 3.50e-03 | 171 | 68 | 4 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.96e-03 | 177 | 68 | 4 | IPR003591 | |
| Domain | LRR_TYP | 3.96e-03 | 177 | 68 | 4 | SM00369 | |
| Domain | DEATH | 4.32e-03 | 27 | 68 | 2 | SM00005 | |
| Domain | - | 4.74e-03 | 93 | 68 | 3 | 1.10.533.10 | |
| Domain | Spectrin_repeat | 4.98e-03 | 29 | 68 | 2 | IPR002017 | |
| Domain | DEATH-like_dom | 5.64e-03 | 99 | 68 | 3 | IPR011029 | |
| Domain | Spectrin/alpha-actinin | 6.04e-03 | 32 | 68 | 2 | IPR018159 | |
| Domain | SPEC | 6.04e-03 | 32 | 68 | 2 | SM00150 | |
| Domain | LRR | 6.20e-03 | 201 | 68 | 4 | PS51450 | |
| Domain | Death | 6.41e-03 | 33 | 68 | 2 | PF00531 | |
| Domain | LRR_1 | 8.34e-03 | 219 | 68 | 4 | PF00560 | |
| Domain | Death_domain | 8.44e-03 | 38 | 68 | 2 | IPR000488 | |
| Domain | DEATH_DOMAIN | 8.44e-03 | 38 | 68 | 2 | PS50017 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.93e-06 | 31 | 46 | 4 | M877 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.34e-04 | 37 | 46 | 3 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.34e-04 | 37 | 46 | 3 | MM15610 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 3.34e-04 | 102 | 46 | 4 | M27648 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 3.41e-04 | 42 | 46 | 3 | M41828 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 3.66e-04 | 43 | 46 | 3 | M41827 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 3.66e-04 | 43 | 46 | 3 | MM15679 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 3.92e-04 | 44 | 46 | 3 | MM15678 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.61e-04 | 10 | 46 | 2 | MM15112 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.38e-04 | 121 | 46 | 4 | M872 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.78e-09 | 10 | 68 | 4 | 22159418 | |
| Pubmed | GPHN DIP2A ASRGL1 NEDD4L ANK2 ANK3 SPTBN1 IQSEC2 SPTBN2 ARFGEF2 KMT2A CORO1B SCRIB ACTR2 TMEM33 | 8.68e-08 | 1431 | 68 | 15 | 37142655 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 1.42e-07 | 6 | 68 | 3 | 23728480 | |
| Pubmed | 1.23e-06 | 549 | 68 | 9 | 38280479 | ||
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 3.20e-06 | 15 | 68 | 3 | 30562487 | |
| Pubmed | The small oligomerization domain of gephyrin converts MLL to an oncogene. | 3.77e-06 | 2 | 68 | 2 | 14751928 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24643514 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17074766 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11781319 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 31209033 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 3.77e-06 | 2 | 68 | 2 | 25383926 | |
| Pubmed | Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia. | 3.77e-06 | 2 | 68 | 2 | 25632041 | |
| Pubmed | Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes. | 3.77e-06 | 2 | 68 | 2 | 15262991 | |
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 3.77e-06 | 2 | 68 | 2 | 26884715 | |
| Pubmed | 5.71e-06 | 18 | 68 | 3 | 37321992 | ||
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 5.71e-06 | 18 | 68 | 3 | 31910261 | |
| Pubmed | Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. | 1.13e-05 | 3 | 68 | 2 | 17620337 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 15611082 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 1.13e-05 | 3 | 68 | 2 | 33410423 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 26845523 | ||
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 1.13e-05 | 3 | 68 | 2 | 34289389 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | USP6 DIP2A WDR45 VAC14 OCIAD1 LRRC37A3 SPTBN1 IQSEC2 SPTBN2 TMCC1 | 1.21e-05 | 925 | 68 | 10 | 28986522 |
| Pubmed | GPHN ASRGL1 NEDD4L ANK2 ANK3 SYT11 SPTBN1 IQSEC2 CORO1B TMCC1 TMEM33 | 1.23e-05 | 1139 | 68 | 11 | 36417873 | |
| Pubmed | Endodermal Wnt signaling is required for tracheal cartilage formation. | 1.23e-05 | 23 | 68 | 3 | 26093309 | |
| Pubmed | 1.41e-05 | 403 | 68 | 7 | 30562941 | ||
| Pubmed | GPHN WDR45 NEDD4L ANK2 ANK3 SPTBN1 IQSEC2 SPTBN2 CORO1B SCRIB | 1.72e-05 | 963 | 68 | 10 | 28671696 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.90e-05 | 281 | 68 | 6 | 28706196 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 21412925 | ||
| Pubmed | Giant ankyrin-B mediates transduction of axon guidance and collateral branch pruning factor sema 3A. | 2.25e-05 | 4 | 68 | 2 | 34812142 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 21186323 | ||
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 2.25e-05 | 4 | 68 | 2 | 24064296 | |
| Pubmed | DIP2A DLG5 OCIAD1 ANK2 ANK3 SPTBN1 SPTBN2 VPS13A SCRIB FAM135A TMCC1 TMEM33 | 2.82e-05 | 1487 | 68 | 12 | 33957083 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 25950943 | ||
| Pubmed | Glial ankyrins facilitate paranodal axoglial junction assembly. | 3.75e-05 | 5 | 68 | 2 | 25362471 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 11203701 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 22632975 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 26784546 | ||
| Pubmed | T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B. | 3.75e-05 | 5 | 68 | 2 | 29720258 | |
| Pubmed | An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. | 3.75e-05 | 5 | 68 | 2 | 19109891 | |
| Pubmed | 4.32e-05 | 197 | 68 | 5 | 36604605 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.47e-05 | 861 | 68 | 9 | 36931259 | |
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 4.47e-05 | 35 | 68 | 3 | 37381005 | |
| Pubmed | Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea. | 4.47e-05 | 35 | 68 | 3 | 32907846 | |
| Pubmed | 4.63e-05 | 486 | 68 | 7 | 20936779 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 5.30e-05 | 37 | 68 | 3 | 27565344 | |
| Pubmed | 5.51e-05 | 105 | 68 | 4 | 9628581 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 12149647 | ||
| Pubmed | Analysis of erythrocyte and platelet membrane proteins in various forms of beta-thalassemia. | 5.62e-05 | 6 | 68 | 2 | 15310273 | |
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 5.62e-05 | 6 | 68 | 2 | 37069398 | |
| Pubmed | Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. | 5.62e-05 | 6 | 68 | 2 | 16687515 | |
| Pubmed | 5.82e-05 | 504 | 68 | 7 | 34432599 | ||
| Pubmed | 6.21e-05 | 39 | 68 | 3 | 24586192 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 6.41e-05 | 697 | 68 | 8 | 28298427 | |
| Pubmed | 7.15e-05 | 708 | 68 | 8 | 39231216 | ||
| Pubmed | 7.23e-05 | 41 | 68 | 3 | 8724849 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 7.86e-05 | 7 | 68 | 2 | 7495297 | |
| Pubmed | 9.56e-05 | 233 | 68 | 5 | 29518331 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 9.69e-05 | 377 | 68 | 6 | 38117590 | |
| Pubmed | Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers. | 1.05e-04 | 8 | 68 | 2 | 23397623 | |
| Pubmed | Msx genes delineate a novel molecular map of the developing cerebellar neuroepithelium. | 1.05e-04 | 8 | 68 | 2 | 38742226 | |
| Pubmed | Isoform diversity in the Arp2/3 complex determines actin filament dynamics. | 1.05e-04 | 8 | 68 | 2 | 26655834 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.24e-04 | 569 | 68 | 7 | 30639242 | |
| Pubmed | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. | 1.34e-04 | 9 | 68 | 2 | 28169360 | |
| Pubmed | Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins. | 1.34e-04 | 9 | 68 | 2 | 29867141 | |
| Pubmed | Polarity inversion reorganizes the stem cell compartment of the trophoblast lineage. | 1.34e-04 | 9 | 68 | 2 | 36989113 | |
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 1.34e-04 | 9 | 68 | 2 | 27325115 | |
| Pubmed | 1.35e-04 | 251 | 68 | 5 | 27507650 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 12665591 | ||
| Pubmed | 1.76e-04 | 421 | 68 | 6 | 36976175 | ||
| Pubmed | THAP4 DIP2A ANK2 ANK3 SPTBN1 IQSEC2 SPTBN2 ARFGEF2 SCRIB EXTL3 | 1.90e-04 | 1285 | 68 | 10 | 35914814 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 2.05e-04 | 11 | 68 | 2 | 17607528 | |
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 33692105 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 23274346 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 33127892 | ||
| Pubmed | Cardiac progenitors instruct second heart field fate through Wnts. | 2.45e-04 | 12 | 68 | 2 | 36649430 | |
| Pubmed | 2.86e-04 | 65 | 68 | 3 | 23453885 | ||
| Pubmed | FGFR2 is associated with hair thickness in Asian populations. | 2.90e-04 | 13 | 68 | 2 | 19590514 | |
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 18796539 | ||
| Pubmed | Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis. | 3.38e-04 | 14 | 68 | 2 | 18022614 | |
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 26123487 | ||
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 25687138 | ||
| Pubmed | Rac1 signaling is critical to cardiomyocyte polarity and embryonic heart development. | 3.38e-04 | 14 | 68 | 2 | 25315346 | |
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 30615824 | ||
| Pubmed | Transcription factor Emx2 controls stereociliary bundle orientation of sensory hair cells. | 3.38e-04 | 14 | 68 | 2 | 28266911 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 34029538 | ||
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 26512061 | ||
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 26883626 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.28e-04 | 497 | 68 | 6 | 36774506 | |
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 19619491 | ||
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 18177851 | ||
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 17767158 | ||
| Pubmed | Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. | 4.44e-04 | 16 | 68 | 2 | 21745462 | |
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 27760317 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 4.94e-04 | 186 | 68 | 4 | 33637726 | |
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 21531785 | ||
| Pubmed | Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall. | 5.03e-04 | 17 | 68 | 2 | 25727890 | |
| Pubmed | 5.04e-04 | 334 | 68 | 5 | 30425250 | ||
| Pubmed | 5.65e-04 | 18 | 68 | 2 | 16839542 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 5.65e-04 | 18 | 68 | 2 | 12119179 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 5.85e-04 | 736 | 68 | 7 | 29676528 | |
| Interaction | RHOB interactions | DIP2A DLG5 NEDD4L ANK3 MRPL16 RRP36 SPTBN1 IQSEC2 SPTBN2 VPS13A SCRIB WLS FAM135A | 2.30e-06 | 840 | 65 | 13 | int:RHOB |
| Interaction | RND3 interactions | 2.65e-06 | 273 | 65 | 8 | int:RND3 | |
| Interaction | RHOJ interactions | PARD6B DIP2A DLG5 NEDD4L MRPL16 SPTBN1 SPTBN2 VPS13A ARFGEF2 SCRIB FAM135A | 5.16e-06 | 633 | 65 | 11 | int:RHOJ |
| Interaction | RHOF interactions | PARD6B DLG5 WDR45 ANK3 MRPL16 SPTBN1 SPTBN2 VPS13A ARFGEF2 SCRIB FAM135A | 9.20e-06 | 673 | 65 | 11 | int:RHOF |
| Interaction | RAB35 interactions | DLG5 OCIAD1 ANK3 SPTBN1 SPTBN2 VPS13A ARFGEF2 SCRIB WLS FAM135A | 1.40e-05 | 573 | 65 | 10 | int:RAB35 |
| Interaction | KCNA3 interactions | DLG5 NEDD4L ANK2 ANK3 CEP112 SPTBN1 VPS13A KMT2A CORO1B SCRIB FAM135A TMEM33 | 1.92e-05 | 871 | 65 | 12 | int:KCNA3 |
| Interaction | KCTD13 interactions | GPHN DIP2A ASRGL1 NEDD4L ANK2 ANK3 SPTBN1 IQSEC2 SPTBN2 ARFGEF2 KMT2A CORO1B SCRIB ACTR2 TMEM33 | 2.84e-05 | 1394 | 65 | 15 | int:KCTD13 |
| Interaction | SHANK3 interactions | 2.90e-05 | 496 | 65 | 9 | int:SHANK3 | |
| Interaction | RHOU interactions | 3.60e-05 | 510 | 65 | 9 | int:RHOU | |
| Interaction | ANK3 interactions | 4.63e-05 | 201 | 65 | 6 | int:ANK3 | |
| Interaction | AGAP2 interactions | 5.90e-05 | 210 | 65 | 6 | int:AGAP2 | |
| Interaction | C11orf52 interactions | 6.30e-05 | 311 | 65 | 7 | int:C11orf52 | |
| Interaction | MAP1LC3B interactions | 6.54e-05 | 551 | 65 | 9 | int:MAP1LC3B | |
| Interaction | RHOQ interactions | 8.49e-05 | 442 | 65 | 8 | int:RHOQ | |
| Interaction | ZFPL1 interactions | 9.32e-05 | 448 | 65 | 8 | int:ZFPL1 | |
| Interaction | THBS3 interactions | 9.57e-05 | 74 | 65 | 4 | int:THBS3 | |
| Interaction | FLOT1 interactions | 1.40e-04 | 475 | 65 | 8 | int:FLOT1 | |
| Interaction | RND1 interactions | 1.41e-04 | 246 | 65 | 6 | int:RND1 | |
| Interaction | RAC3 interactions | 1.58e-04 | 619 | 65 | 9 | int:RAC3 | |
| Interaction | CHRNA4 interactions | 1.62e-04 | 159 | 65 | 5 | int:CHRNA4 | |
| Interaction | OCLN interactions | 1.98e-04 | 500 | 65 | 8 | int:OCLN | |
| Interaction | DIRAS3 interactions | 1.98e-04 | 262 | 65 | 6 | int:DIRAS3 | |
| Interaction | DNAJC5 interactions | 2.11e-04 | 378 | 65 | 7 | int:DNAJC5 | |
| Interaction | TNIK interactions | 2.22e-04 | 381 | 65 | 7 | int:TNIK | |
| Interaction | YWHAZ interactions | PARD6B MSX2 DLG5 NEDD4L CEP112 SPTBN1 IQSEC2 SPTBN2 MDC1 KMT2A SCRIB TMCC1 ACTR2 | 2.56e-04 | 1319 | 65 | 13 | int:YWHAZ |
| Interaction | KALRN interactions | 2.62e-04 | 96 | 65 | 4 | int:KALRN | |
| Cytoband | 17q24.1 | 6.02e-05 | 8 | 68 | 2 | 17q24.1 | |
| Cytoband | 8p21 | 4.04e-04 | 20 | 68 | 2 | 8p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 9.15e-04 | 503 | 68 | 5 | chr6p21 | |
| Cytoband | 20q13.13 | 1.04e-03 | 32 | 68 | 2 | 20q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 1.08e-03 | 135 | 68 | 3 | chr8p21 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.46e-05 | 7 | 39 | 2 | 1113 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-10 | 196 | 68 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-08 | 198 | 68 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.70e-07 | 197 | 68 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 5.24e-06 | 164 | 68 | 5 | 334f376350c9cf92611d0f75b2e18a102f4c116a | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-05 | 191 | 68 | 5 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 194 | 68 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 196 | 68 | 5 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 198 | 68 | 5 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 198 | 68 | 5 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 198 | 68 | 5 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-05 | 200 | 68 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-4|TCGA-Kidney / Sample_Type by Project: Shred V9 | 5.76e-05 | 137 | 68 | 4 | 758aa466a01265ed67b94f1578b4099956506271 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.77e-05 | 157 | 68 | 4 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.03e-04 | 159 | 68 | 4 | ebd840ac2b07e62086ee7b5bb01c21804a0fdc7b | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 164 | 68 | 4 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 166 | 68 | 4 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 168 | 68 | 4 | 2163e6774eb7a3d010422e4d59be5e45b4158329 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 170 | 68 | 4 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-04 | 173 | 68 | 4 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 175 | 68 | 4 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-04 | 181 | 68 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.87e-04 | 186 | 68 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.87e-04 | 186 | 68 | 4 | a7a2ef8392a045a62fa4d0983577711d5d397dc4 | |
| ToppCell | E17.5-Epithelial|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-04 | 187 | 68 | 4 | fdabe716ce67f2eede90548198cbe20bbf693570 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.91e-04 | 187 | 68 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | E17.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-04 | 190 | 68 | 4 | 8e9ba1f1af520564a1a7dfa9ef74ef5f0d0bf0d5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 190 | 68 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-04 | 190 | 68 | 4 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | E17.5-Epithelial-epithelial_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.07e-04 | 191 | 68 | 4 | 68b717fce7d9349ef56255ee0c5e57fc67e50fd8 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.11e-04 | 192 | 68 | 4 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 2.11e-04 | 192 | 68 | 4 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 2.11e-04 | 192 | 68 | 4 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 193 | 68 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 193 | 68 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.20e-04 | 194 | 68 | 4 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.20e-04 | 194 | 68 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PND01-Epithelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 194 | 68 | 4 | d21db5e942966ed44bc78ff50130a201fc627074 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 194 | 68 | 4 | 54975e663ed4414b99b3c9a1aa6335613946470f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.20e-04 | 194 | 68 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.24e-04 | 195 | 68 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | 43164511f32e4591cb5399182fbac0b911716233 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | 9337111d75a487abc02969337718c30b1fe81379 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.24e-04 | 195 | 68 | 4 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.24e-04 | 195 | 68 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.24e-04 | 195 | 68 | 4 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-04 | 195 | 68 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.29e-04 | 196 | 68 | 4 | 511e9846d204b2346b17d1a4142c3bb484b08e32 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 196 | 68 | 4 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-04 | 196 | 68 | 4 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-04 | 196 | 68 | 4 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 2.29e-04 | 196 | 68 | 4 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | droplet-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 196 | 68 | 4 | b880c9665d42c76ea1971d4e49d7ecf72fcfafb6 | |
| ToppCell | AT2_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-04 | 197 | 68 | 4 | c36513e893488c4299119d4fba6ef0fd72610ee6 | |
| ToppCell | Severe-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.38e-04 | 198 | 68 | 4 | 8402421dc060926e968efe39a4e907f1e8ae5b1f | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.42e-04 | 199 | 68 | 4 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.42e-04 | 199 | 68 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.42e-04 | 199 | 68 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.42e-04 | 199 | 68 | 4 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.42e-04 | 199 | 68 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 200 | 68 | 4 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 200 | 68 | 4 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC2|ICU-SEP / Disease, condition lineage and cell class | 2.47e-04 | 200 | 68 | 4 | 09d5c3a3d2b42b15c769dc2bc14b6c0d5cc38f91 | |
| Disease | Neurodevelopmental Disorders | 2.31e-06 | 93 | 67 | 5 | C1535926 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 3.04e-05 | 4 | 67 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 7.57e-05 | 6 | 67 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 1.06e-04 | 7 | 67 | 2 | C1868720 | |
| Disease | unipolar depression, response to escitalopram, response to citalopram, mood disorder | 5.23e-04 | 15 | 67 | 2 | EFO_0003761, EFO_0004247, EFO_0006329, EFO_0007871 | |
| Disease | susceptibility to mononucleosis measurement | 5.27e-04 | 69 | 67 | 3 | EFO_0008403 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 6.72e-04 | 75 | 67 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | cortical surface area measurement | MSX2 ARID1B CSGALNACT2 ANK3 CEP112 SPTBN1 MDC1 OSTN EXTL3 WLS | 8.70e-04 | 1345 | 67 | 10 | EFO_0010736 |
| Disease | Epilepsy, Cryptogenic | 8.72e-04 | 82 | 67 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 8.72e-04 | 82 | 67 | 3 | C0751111 | |
| Disease | Aura | 8.72e-04 | 82 | 67 | 3 | C0236018 | |
| Disease | Colorectal Carcinoma | 1.06e-03 | 702 | 67 | 7 | C0009402 | |
| Disease | unipolar depression, depressive symptom measurement | 1.59e-03 | 26 | 67 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | Acute monocytic leukemia | 1.59e-03 | 26 | 67 | 2 | C0023465 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.79e-03 | 227 | 67 | 4 | EFO_0004346, EFO_0010736 | |
| Disease | Epilepsy | 1.98e-03 | 109 | 67 | 3 | C0014544 | |
| Disease | lung carcinoma, family history of lung cancer | 1.98e-03 | 29 | 67 | 2 | EFO_0001071, EFO_0006953 | |
| Disease | Epileptic encephalopathy | 2.12e-03 | 30 | 67 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PYIKMTILPDKRHRV | 196 | Q9BT88 | |
| PDSKMTPLRFRKRTL | 261 | Q9BXY5 | |
| PIKLARLVMEKTPHC | 101 | Q7L266 | |
| PFEHIMKKNRSPTIR | 1186 | Q9Y6D5 | |
| VVDMKPFVLKLPHRT | 21 | Q8N8E3 | |
| HERKCEPIVMTVPRK | 341 | Q9BR76 | |
| CIKMVSRTTPYEPKR | 1001 | Q12882 | |
| QTHFESKMEIPPRRR | 1901 | Q8NFD5 | |
| CRPHRKTFMPSLVVK | 341 | Q8NAV2 | |
| IRTMKPLPRHFILFI | 556 | Q96K78 | |
| PKPKRVFLQHMTRTF | 681 | Q7Z2K6 | |
| KIRIEDPPRRKHMVF | 341 | P61160 | |
| HKFSFDIMPTARPKR | 386 | Q86UN2 | |
| KVARRHRMSPFPLTS | 311 | Q9NQX3 | |
| RKKPHIVISMPQDFR | 126 | Q9BYG5 | |
| TLEPRRRKFHKPITM | 1221 | Q01484 | |
| RSRMTHRTPKVKKSP | 1311 | O60309 | |
| FHPKPKIRTRKSSRM | 1101 | Q14676 | |
| AKVKHSRPRREMASP | 361 | Q8NHJ6 | |
| RMIVGKKPVLSLPHR | 956 | Q5JU85 | |
| RASMKIPSRIPHRVE | 31 | Q9P2D6 | |
| MVHRFSKRRDSPLPV | 261 | Q8TCB6 | |
| ATVRKLAKPPHLIMR | 3171 | Q96JB1 | |
| MHASPPRKARVRIAS | 1061 | Q8TDM6 | |
| RRKTPRHKQPTLLMV | 26 | Q8N319 | |
| RIMITSHFPPKTRLS | 331 | Q9HC58 | |
| PPIHLHRMKSLIRSK | 306 | Q68CR7 | |
| RKVVDHPKRRFGIPM | 106 | P61366 | |
| EPTKTPILHVRRMVF | 36 | Q8NB91 | |
| SVRPMHERVPKKEVK | 221 | Q9NX40 | |
| RITMNPKVFKLHPRS | 276 | Q92838 | |
| RHVTLFRPFGPLMKV | 246 | Q8N6G5 | |
| TPRRRMKKSLSAPLH | 201 | Q53HC0 | |
| KFVLGPTPARRHMVK | 241 | O43559 | |
| MNFLVSHITRKPPIK | 836 | O43909 | |
| RHHGMRIIIPPRKCT | 1001 | Q12955 | |
| EPRRRKFHKPITMTI | 1206 | Q12955 | |
| AKCKHRRLRFPPMDT | 31 | Q5JRC9 | |
| TRFDMHKRSPLLRAP | 686 | Q03164 | |
| RKMPMPSKRRSVLVH | 111 | Q14689 | |
| IKTPAFHPQRMIISR | 576 | A6NJU9 | |
| PMRSKKIFGSVHPVR | 186 | P26022 | |
| AKPRRHPSTKLSMVG | 116 | Q6ZVC0 | |
| PRHMSPTTCTLRKHK | 126 | P35548 | |
| RIKFTHCLVPKMPTN | 186 | Q6NXP2 | |
| VHSPDRMLDSPKRKR | 881 | Q9NXL9 | |
| APFKPITRKSVGHRM | 126 | Q9NX20 | |
| KTPRKMFRHTDSLFP | 431 | Q08AM6 | |
| HKSRKRRLFCTMEPE | 256 | Q9UPQ4 | |
| RKQVLTKPSVHMPER | 716 | B4DYI2 | |
| FTKPVLSVRMRHDKI | 101 | Q9Y484 | |
| QRRATPHPSELKVMK | 471 | Q14160 | |
| PKPTKGRMRIHCLEN | 101 | Q01082 | |
| HITIPRKRMFTPRKL | 301 | Q96F83 | |
| KAFISLPSVRRHMIK | 176 | Q8TBZ8 | |
| KRPHVKKATPRMIGL | 1461 | Q96RL7 | |
| EILPKPTKGRMRIHC | 101 | O15020 | |
| TKRRPPLSHMISLFI | 676 | Q12767 | |
| VPPKMKRGTSLHSRR | 111 | O94876 | |
| APLMFSRRHSLKKVP | 621 | A0A0J9YWL9 | |
| SRRHSLKKVPVMPKE | 626 | A0A0J9YWL9 | |
| FSRRHSLKKVPVMPK | 686 | A0A0J9YWL9 | |
| KHRPLEMSAKIRVPF | 91 | Q96EU6 | |
| TREMPQSKPKLRSRH | 501 | Q9BWV7 | |
| DRAFPLKPMVHRKSC | 136 | Q53FD0 | |
| RFAVKPKRDRHIMLT | 391 | Q96C00 | |
| PKRDRHIMLTFSLRP | 396 | Q96C00 | |
| KVVHRPMGTRKHLVP | 246 | O96014 | |
| MAHERVPRKLKCTFT | 151 | Q5T9L3 | |
| RKPMHRECGFIRLKP | 476 | Q8WY91 | |
| MPLIVPCTVHTRKKD | 901 | P35125 | |
| EHIIMKPACPLFVRR | 216 | P57088 | |
| EDPRLKFPVHMRSKT | 526 | Q96PU5 |